Concepedia

P. Tanswell

PT

Statistics

Publications

31

Citations

2.1K

H-Index

22

Active since

1974

Affiliations

Boehringer Ingelheim (Germany)(Current)

Universität Ulm

University of Oxford

University of Applied Sciences Biberach

Pharmazeutische Fabrik Dr. Reckeweg (Germany)

P. Tanswell is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1974–2014

31

Publications

31

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

Andrew M. Scott, G. Wiseman, Sydney Welt et al. · PubMed · 2003 · 442 citations

, , +17

Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

Ralf‐Dieter Hofheinz, Salah‐Eddin Al‐Batran, Frank Hartmann et al. · Oncology Research and Treatment · 2003 · 366 citations

, , +17

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction

P. Tanswell, Ulrich Tebbe, Karl-Ludwig Neuhaus et al. · Journal of the American College of Cardiology · 1992 · 125 citations

, , +16

Nuclear‐Magnetic‐Resonance Study of the Active‐Site Structure of Yeast Phosphoglycerate Kinase

P. Tanswell, Edward W. Westhead, Robert J. P. Williams · European Journal of Biochemistry · 1976 · 92 citations · Full text

, , +17

Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects

P. Tanswell, E. Seifried, Peter C A F Su et al. · Clinical Pharmacology & Therapeutics · 1989 · 88 citations

, , +13

1–5 of 31